• All Courts
  • Federal Courts
  • Bankruptcies
  • PTAB
  • ITC
Track Search
Export
Download All
Active Filters
Displaying 39-53 of 236 results

1056 Exhibit: EX 1056 Nakov et al, Correlation between Ulcerative Colitis Endoscop...

Document IPR2023-01444, No. 1056 Exhibit - EX 1056 Nakov et al, Correlation between Ulcerative Colitis Endoscopic (P.T.A.B. Nov. 22, 2023)

cite Cite Document
Analyze

1004 Exhibit: EX 1004 20170225 Internet Archives Stelara label 761044lbl

Document IPR2023-01444, No. 1004 Exhibit - EX 1004 20170225 Internet Archives Stelara label 761044lbl (P.T.A.B. Nov. 22, 2023)

cite Cite Document
Analyze

1025 Exhibit: EX 1025 US Patent Publication No US 20090181027 A1 ’027 Publ

Document IPR2023-01444, No. 1025 Exhibit - EX 1025 US Patent Publication No US 20090181027 A1 ’027 Publ (P.T.A.B. Nov. 22, 2023)

cite Cite Document
Analyze

1003 Exhibit: EX 1003 NCT 236 A Study to Evaluate the Safety and Efficacy

Document IPR2023-01444, No. 1003 Exhibit - EX 1003 NCT 236 A Study to Evaluate the Safety and Efficacy (P.T.A.B. Nov. 22, 2023)

cite Cite Document
Analyze

1044 Exhibit: EX 1044 Glossary of Common Site Terms, ClinicalTrialsgov Oct 2021

Document IPR2023-01444, No. 1044 Exhibit - EX 1044 Glossary of Common Site Terms, ClinicalTrialsgov Oct 2021 (P.T.A.B. Nov. 22, 2023)

cite Cite Document
Analyze

1042 Exhibit: EX 1042 D’Haens et al, A Review of Activity Indices and Efficacy End

Document IPR2023-01444, No. 1042 Exhibit - EX 1042 D’Haens et al, A Review of Activity Indices and Efficacy End (P.T.A.B. Nov. 22, 2023)

cite Cite Document
Analyze

1014 Exhibit: EX 1014 Aggeletopoulou et al, Interleukin 12interleukin 23 pathway

Document IPR2023-01444, No. 1014 Exhibit - EX 1014 Aggeletopoulou et al, Interleukin 12interleukin 23 pathway (P.T.A.B. Nov. 22, 2023)

cite Cite Document
Analyze

1056 Exhibit: EX 1056 Nakov et al, Correlation between Ulcerative Colitis Endoscop...

Document IPR2023-01444, No. 1056 Exhibit - EX 1056 Nakov et al, Correlation between Ulcerative Colitis Endoscopic (P.T.A.B. Nov. 22, 2023)

cite Cite Document
Analyze

1034 Exhibit: EX 1034 Kolios et al, Paradoxical ulcerative colitis during adalimumab

Document IPR2023-01444, No. 1034 Exhibit - EX 1034 Kolios et al, Paradoxical ulcerative colitis during adalimumab (P.T.A.B. Nov. 22, 2023)

cite Cite Document
Analyze

1044 Exhibit: EX 1044 Glossary of Common Site Terms, ClinicalTrialsgov Oct 2021

Document IPR2023-01444, No. 1044 Exhibit - EX 1044 Glossary of Common Site Terms, ClinicalTrialsgov Oct 2021 (P.T.A.B. Nov. 22, 2023)

cite Cite Document
Analyze

1006 Exhibit: EX 1006 Vedolizumab label Entyvio VMB245 R1 FULL INFORMATION...

Document IPR2023-01444, No. 1006 Exhibit - EX 1006 Vedolizumab label Entyvio VMB245 R1 FULL INFORMATION 300 mg 2014 (P.T.A.B. Nov. 22, 2023)

cite Cite Document
Analyze

1065 Exhibit: EX 1065 webarchive of Chemical Database for Ustekinumab

Document IPR2023-01444, No. 1065 Exhibit - EX 1065 webarchive of Chemical Database for Ustekinumab (P.T.A.B. Nov. 22, 2023)

cite Cite Document
Analyze

1026 Exhibit: EX 1026 Feagan et al, Ustekinumab as Induction and Maintenance Th...

Document IPR2023-01444, No. 1026 Exhibit - EX 1026 Feagan et al, Ustekinumab as Induction and Maintenance Therapy (P.T.A.B. Nov. 22, 2023)

cite Cite Document
Analyze

1049 Exhibit: EX 1049b US Patent Application Publication 20200262908 A1 part 2 ...

Document IPR2023-01444, No. 1049-2 Exhibit - EX 1049b US Patent Application Publication 20200262908 A1 part 2 of 2 (P.T.A.B. Nov. 22, 2023)

cite Cite Document
Analyze

1036 Exhibit: EX 1036b Excerpts from US Patent 10,961,307 file history 2 of 2

Document IPR2023-01444, No. 1036-2 Exhibit - EX 1036b Excerpts from US Patent 10,961,307 file history 2 of 2 (P.T.A.B. Nov. 22, 2023)

cite Cite Document
Analyze
<< 1 2 3 4 5 6 7 ... 15 16 17 >>